| Active Ingredient | Fenbendazole |
| Manufacturer | Kachhela Medex Pvt. Ltd. |
| Packaging | 10 tablet in 1 strip |
| Strength | 1000 mg |
| Delivery Time | 14-16 Days |
| SKU | 15 |
| Pack | Price | Qty | Add |
|---|---|---|---|
| 100 Tablets | $200.00 | ||
| 300 Tablets | $450.00 | ||
| 500 Tablets | $600.00 | ||
| 800 Tablets | $900.00 | ||
| 1000 Tablets | $1,050.00 |
Fenbendazole 1000mg is a high-strength benzimidazole antiparasitic tablet produced by Kachhela Medex Pvt. Ltd. Fenbendazole belongs to the benzimidazole class of anthelmintic compounds with several decades of established use in veterinary medicine for treating and controlling a broad spectrum of parasitic worm infections in animals.
The 1000mg strength provides the highest per-tablet Fenbendazole dose in this product format — making it a practical high-dose option for larger animals or situations where a significantly higher weight-based dose is required, as determined entirely by a qualified veterinarian or healthcare professional.
This formulation should only be used following proper professional evaluation and appropriate guidance. It must not be used for self-treatment of any condition.
Fenbendazole 1000mg Tablets are manufactured by Kachhela Medex Pvt. Ltd., a licensed pharmaceutical manufacturer with an established portfolio of antiparasitic and other pharmaceutical products. The company operates certified manufacturing facilities that function in compliance with applicable Good Manufacturing Practice (GMP) standards, ensuring rigorous quality control procedures are applied throughout every stage of production.
Each batch of Fenbendazole 1000mg Tablets undergoes comprehensive testing for purity, potency, and consistency to ensure that every tablet supplied meets the required pharmaceutical quality specifications.
The product contains Fenbendazole 1000mg as the sole active ingredient per tablet, is presented in oral tablet form, and is packaged in strips of 10 tablets per strip for practical storage and dispensing. It belongs to the benzimidazole antiparasitic drug class and is available as a product requiring professional supervision before use.
Fenbendazole demonstrates significantly stronger binding affinity for parasitic beta-tubulin compared to mammalian beta-tubulin — which forms the established basis of its selective antiparasitic activity in veterinary use.
For veterinary use, administer exactly according to veterinary instructions and applicable product labeling. Administer the tablet whole with a sufficient amount of water unless otherwise instructed by the supervising veterinarian.
The tablet may be given with or without food as advised by the supervising professional. Ensure the complete dose is consumed at each administration.
Do not crush or alter the tablet form unless specifically directed. Follow the full prescribed treatment schedule without skipping or adjusting doses independently.
For any use under healthcare professional supervision, follow the exact guidance provided by the supervising qualified professional. Do not independently adjust the dose, strength, frequency, or duration of use. Report any adverse reactions to the supervising professional promptly.
There is no established FDA-approved human dosage for Fenbendazole.
The 1000mg tablet strength is particularly practical for larger animals where weight-based dose calculations require a higher amount per administration, as it reduces the number of tablets needed compared to using multiple lower-strength tablets.
For any use considered under healthcare professional supervision, the supervising provider determines the appropriate amount, frequency, and duration based on individual clinical circumstances.
Do not independently determine, adjust, or compare dosing without direct professional guidance.
Treatment duration depends entirely on the type of parasitic infection and the professional assessment of the supervising veterinarian or healthcare provider.
A 3-day consecutive daily course is widely referenced in veterinary Fenbendazole protocols for many common parasitic infections. Some conditions may require extended treatment periods or repeated cycles based on follow-up parasitological assessment and clinical response.
Complete the full prescribed course without stopping early even when visible symptoms appear to resolve before treatment ends. Periodic stool examinations or other follow-up assessments may be recommended to confirm successful parasite elimination. Do not discontinue or extend treatment without direct professional guidance.
If the next scheduled dose is approaching, skip the missed dose and continue the regular prescribed schedule. Seek guidance from the supervising veterinarian or healthcare professional if uncertain about how to proceed.
Commonly noted in veterinary use:
In limited human cases reported under medical supervision:
Seek immediate professional attention if:
Regular monitoring is strongly recommended during any period of supervised use.
Fenbendazole 1000mg is not FDA approved for human use and any human use must only occur under direct qualified medical supervision.
Pregnancy in humans or breeding animals requires consultation with a qualified healthcare professional or veterinarian before any use.
Breastfeeding individuals should seek qualified medical advice prior to any use.
Liver impairment in animals or humans requires cautious use with appropriate monitoring during the treatment period.
This product must be kept out of reach of children at all times. The recommended dosage must not be exceeded under any circumstances.
All medicines, supplements, and other products currently in use must be disclosed to the supervising professional before starting Fenbendazole 1000mg.
The complete instructions provided by the supervising professional must be followed throughout the entire treatment period.
Limited formal drug interaction data exists for Fenbendazole. Based on currently available information, other antiparasitic medicines used concurrently may require careful professional assessment before proceeding.
Medicines metabolized through liver enzyme pathways may interact with Fenbendazole due to its potential effect on liver enzyme activity.
Salicylanilide compounds are referenced in veterinary literature as having potential for enhanced adverse effects when used concurrently with Fenbendazole.
Always inform the supervising veterinarian or healthcare professional about every medicine, supplement, and product currently in use before starting Fenbendazole 1000mg Tablets.
Q: What is Fenbendazole 1000mg used for?
A: Fenbendazole 1000mg is a high-strength antiparasitic compound used in veterinary practice for treating roundworm, hookworm, whipworm, certain tapeworm, and Giardia infections in animals. Any use outside established veterinary applications must be under direct qualified professional supervision.
Q: Why choose the 1000mg strength over lower Fenbendazole strengths?
A: The 1000mg tablet provides the highest single-tablet Fenbendazole dose in this format. For larger animals or situations requiring a higher weight-based dose, the 1000mg tablet significantly reduces the number of tablets needed per administration compared to lower-strength formulations — as determined by a supervising veterinarian.
Q: Is Fenbendazole 1000mg FDA-approved for human use?
A: No. Fenbendazole does not hold FDA approval for any human medical indication. It is classified as a veterinary antiparasitic compound. Any consideration of human use must only be under the direct supervision of a qualified healthcare professional.
Q: Who manufactures Fenbendazole 1000mg Tablets?
A: These tablets are manufactured by Kachhela Medex Pvt. Ltd. in GMP-compliant certified pharmaceutical facilities with comprehensive batch testing for consistent product quality.
Q: How long does a Fenbendazole 1000mg treatment course typically last?
A: In veterinary practice, a 3-day consecutive daily course is widely referenced for many parasitic infections. Some conditions may require extended or repeated cycles based on follow-up assessment. Duration is always determined by the supervising veterinarian or healthcare professional based on individual assessment.
Q: What side effects should be monitored?
A: In veterinary use, mild digestive upset, temporary appetite loss, diarrhea, and transient lethargy have been noted. In supervised human contexts, nausea, stomach discomfort, dizziness, and elevated liver enzyme levels have been reported. Seek immediate professional attention for any severe or unexpected adverse reaction.
Q: How should Fenbendazole 1000mg Tablets be stored?
A: Store at room temperature below 25°C away from sunlight and moisture in the original 10-tablet strips. Keep out of reach of children and pets at all times and do not use past the printed expiry date on the packaging.
Medical Disclaimer: The information shown above is for educational purposes only. Please consult your doctor or a licensed healthcare professional before taking any medicine. Never start, stop, or change any treatment without professional medical advice.
Reviews
There are no reviews yet.